AOA 2025: A review of myopic retinal complications with Dr Carolyn Majcher
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
AOA 2025: Perfluorohexyloctane demonstrates early symptom relief and patient satisfaction
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
AOA 2025: New ways to fix old issues in scleral lenses
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
AOA 2025: An OD's guide to swollen nerves with Dr Mohammad Rafieetary
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
AOA 2025: Collaborative management of myopia from A to Z
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
What you missed in glaucoma, dry eye, myopia, and more at CCS 2025
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
CCS 2025: Clinical pearls and forward thinking are the key to success in myopia management
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
CCS 2025: Collaborative retinal disease management in the preoperative refractive surgery patient
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
CCS 2025: Getting to know the refractive surgery patient population
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Collaborating more effectively on neovascular retinal cases
June 2nd 2025At the Collaborative Care Symposium, Rachelle Lin, OD, MS, FAAO, highlighted how newer retinal therapies are addressing treatment gaps by offering extended dosing intervals without compromising efficacy—ultimately easing the burden on both patients and providers.
CCS 2025: Taking a contemporary approach to dry eye disease with Dr Mitch Ibach
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
ARVO 2025: Miebo demonstrates favorable tolerability in prescription refill rates
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, details the key takeaways from a poster presentation she participated in during ARVO 2025.
ARVO 2025: The early adoption and utilization of perfluorohexoloctane (Miebo)
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.